Abnormal signaling at corticotropin-releasing factor CRF 1 and CRF 2 receptors might
contribute to the pathophysiology of stress-related disorders such as anxiety, depression and …

Corticotropin-releasing factor (CRF) and the related urocortin peptides mediate behavioral,
cognitive, autonomic, neuroendocrine and immunologic responses to aversive stimuli by …

Receptors for corticotropin-releasing factor (CRF) are members of a family of G protein-coupled
receptors (“Family B”) that respond to a variety of structurally dissimilar releasing factors, …

Packed beds of catalyst particles are normally described using models that contain a
number of empirical parameters. The development of computer technology and CFD models …

The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key
properties of over 1750 human drug targets with their pharmacology, plus links to an open …

Process Intensification is the strategy of making significant reductions in the size of a chemical
plant in order to achieve a given production objective. Innovations in catalytic reactors, …

The biochemical and behavioral effects of a nonpeptidic, selective, and brain-penetrant
agonist at the ORL1 receptor are reported herein. This low molecular weight compound {(1S,3aS…

Chemisorption, ir, and XPS data indicate that rhenium atoms covered with chemisorbed sulfur
atoms divide the metal surface of platinum-containing catalysts into ensembles consisting …

Markers of hyperactive central corticotropin releasing factor (CRF) systems and CRF‐related
single nucleotide polymorphisms (SNPs) have been identified in patients with anxiety and …

In this paper, the mass and heat transfer characteristics of a composite structured catalytic
reactor packing (Composite Structured Packing (CSP)) are investigated. A CSP consists of a …